- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

MALMÖ, SWEDEN / ACCESS Newswire / February 7, 2025 / Ascelia Pharma (STO ... Following successful Phase 1 results, Oncoral is now prepared for Phase 2 clinical development.

Emcure Pharmaceuticals on Thursday reported a 30.3% year-on-year ... The company’s EBITDA rose 23.2% YoY to Rs 362 crore crore, while the EBITDA margin rose 80 basis points YoY to 18.4%. The EBITDA ...

Nippon India Multi Cap Fund (G) 122.85 10,00,000 0.33 Nippon India Multi Cap Fund (IDCW) 122.85 10,00,000 0.33 Nippon India Multi Cap Fund (B) 122.85 10,00,000 0.33 ...

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the disclosure regarding an Order received by Company''s ...

Emcure Pharmaceuticals Ltd reported a 30.3% year-on-year (YoY) increase in net profit, which rose to ₹156 crore in the third quarter of FY25, up from ₹119.7 crore in the same period last year. The ...

Emcure Pharma on February 6 reported a net profit of Rs 153.72 crore for the third quarter of the current financial year. This marks a rise of over 35 percent from the Rs 113.45 crore net profit ...

The total estimated value of the contract is seen at Rs 247.55 crore. Emcure Pharmaceuticals: The drugmaker company has received an order confirming demand for tax, interest, and penalty from the ...

(MENAFN- Adfactors PR) Bengaluru, January 31, 2025: Cricket legend M.S. Dhoni and Emcure Pharma’s Whole-Time Director Namita Thapar have come together in a powerful conversation to highlight the ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

HOOKIPA Pharma (HOOK) announced that enrollment is complete in the Phase 1b clinical trial evaluating HB-500 for the treatment of HIV, with 30 participants enrolled across five sites in the United ...